Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention
The immunosuppressive agent mycophenolate is used extensively in kidney transplantation,
yet dosing strategy applied varies markedly from fixed dosing (“one-dose-fits-all”), to …
yet dosing strategy applied varies markedly from fixed dosing (“one-dose-fits-all”), to …
[HTML][HTML] Fixed-or controlled-dose mycophenolate mofetil with standard-or reduced-dose calcineurin inhibitors: the Opticept trial
RS Gaston, B Kaplan, T Shah, D Cibrik… - American Journal of …, 2009 - Elsevier
Mycophenolate mofetil (MMF) was developed with cyclosporine as a fixed-dose
immunosuppressant. More recent data indicate a relationship between mycophenolic acid …
immunosuppressant. More recent data indicate a relationship between mycophenolic acid …
Quality of life after kidney transplantation: the bright side of life?
F Dobbels, L De Bleser, S De Geest, RN Fine - Advances in chronic kidney …, 2007 - Elsevier
This review describes the state-of-the-art on quality of life (QOL) in kidney transplant (KTx)
recipients. More specifically, posttransplant QOL is compared with the pretransplant …
recipients. More specifically, posttransplant QOL is compared with the pretransplant …
[HTML][HTML] Rates of first infection following kidney transplant in the United States
We studied the incidence, trends and clinical correlates of infections following kidney
transplantation in the United States Renal Data System over the years 1995–2003 in 46,471 …
transplantation in the United States Renal Data System over the years 1995–2003 in 46,471 …
Probability, predictors, and prognosis of posttransplantation glomerulonephritis
W Chailimpamontree, S Dmitrienko, G Li… - Journal of the …, 2009 - journals.lww.com
Glomerulonephritis (GN) is the leading cause of chronic kidney disease among recipients of
renal transplants. Because modern immunosuppressive regimens have reduced the …
renal transplants. Because modern immunosuppressive regimens have reduced the …
[HTML][HTML] Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19
While older males are at the highest risk for poor coronavirus disease 2019 (COVID-19)
outcomes, it is not known if this applies to the immunosuppressed recipient of a solid organ …
outcomes, it is not known if this applies to the immunosuppressed recipient of a solid organ …
Structure validity of the Pittsburgh Sleep Quality Index in renal transplant recipients: a confirmatory factor analysis
H Burkhalter, SM Sereika, S Engberg… - Sleep and Biological …, 2010 - Springer
The primary aim of this study was to fit and test the hypothesized three-factor model of the
Pittsburgh Sleep Quality Index (PSQI) reported by Cole (2006) in renal transplant (RTx) …
Pittsburgh Sleep Quality Index (PSQI) reported by Cole (2006) in renal transplant (RTx) …
Vascularized composite allotransplantation and tissue engineering
EM Bueno, JR Diaz-Siso, GC Sisk… - Journal of …, 2013 - journals.lww.com
For many living with the devastating aftermath of disfiguring facial injuries, extremity
amputations, and other composite tissues defects, conventional reconstruction offers limited …
amputations, and other composite tissues defects, conventional reconstruction offers limited …
The role of personal characteristics in the relationship between health and psychological distress among kidney transplant recipients
T Schulz, J Niesing, RE Stewart, R Westerhuis… - Social Science & …, 2012 - Elsevier
Although kidney transplantation improves overall quality of life and physical functioning,
improvements of psychological distress are often modest. However, apparent stressors such …
improvements of psychological distress are often modest. However, apparent stressors such …
Concomitant Polyoma BK Virus and West Nile Virus in Renal Allografts
Surveillance of the renal allograft recipient is essential when monitoring renal function to
detect the early onset of rejection and alter therapeutic treatments to treat acute rejection or …
detect the early onset of rejection and alter therapeutic treatments to treat acute rejection or …